CureVac N.V. (NASDAQ: CVAC) experienced a significant stock surge following a favorable decision in a patent dispute. The most recent market check showed that CVAC
Following the announcement of a major strategic initiative, CureVac N.V. (NASDAQ: CVAC) witnessed a bullish trend in its shares on the US stock charts. The
Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter
China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio
Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the
CBAK Energy Technology Inc. (CBAT) stock soared 51.22% to $9.3 in pre-market trading. Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) shares are trading
IMAC Holdings Inc. (IMAC) stock plunged -13.16% to $1.32 in the pre-market trading after the company reported third-quarter earnings. The most recent rating by Ascendiant
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.